nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—migraine—Acetylsalicylic acid—coronary artery disease	0.396	1	CpDpCtD
Ergotamine—HTR2A—coronary artery disease	0.0915	1	CbGaD
Ergotamine—HTR1B—Penbutolol—coronary artery disease	0.0506	0.159	CbGbCtD
Ergotamine—HTR1A—Penbutolol—coronary artery disease	0.0317	0.0995	CbGbCtD
Ergotamine—ABCB1—Ticagrelor—coronary artery disease	0.0173	0.0544	CbGbCtD
Ergotamine—CYP1A2—Gemfibrozil—coronary artery disease	0.0141	0.0443	CbGbCtD
Ergotamine—CYP1A2—Clopidogrel—coronary artery disease	0.0122	0.0384	CbGbCtD
Ergotamine—ABCB1—Perindopril—coronary artery disease	0.0107	0.0336	CbGbCtD
Ergotamine—ABCB1—Clopidogrel—coronary artery disease	0.0107	0.0336	CbGbCtD
Ergotamine—CYP3A4—Ticagrelor—coronary artery disease	0.0104	0.0326	CbGbCtD
Ergotamine—ABCB1—Telmisartan—coronary artery disease	0.00936	0.0294	CbGbCtD
Ergotamine—ABCB1—Pitavastatin—coronary artery disease	0.00936	0.0294	CbGbCtD
Ergotamine—CYP3A4—Fenofibrate—coronary artery disease	0.00925	0.0291	CbGbCtD
Ergotamine—ABCB1—Lisinopril—coronary artery disease	0.00887	0.0278	CbGbCtD
Ergotamine—ABCB1—Enalapril—coronary artery disease	0.00887	0.0278	CbGbCtD
Ergotamine—ABCB1—Timolol—coronary artery disease	0.00754	0.0237	CbGbCtD
Ergotamine—CYP3A4—Gemfibrozil—coronary artery disease	0.0074	0.0232	CbGbCtD
Ergotamine—ABCB1—Ezetimibe—coronary artery disease	0.0069	0.0217	CbGbCtD
Ergotamine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00672	0.0211	CbGbCtD
Ergotamine—ABCB1—Captopril—coronary artery disease	0.00664	0.0208	CbGbCtD
Ergotamine—HTR2B—cardial valve—coronary artery disease	0.00656	0.246	CbGeAlD
Ergotamine—CYP3A4—Clopidogrel—coronary artery disease	0.00641	0.0201	CbGbCtD
Ergotamine—ABCB1—Simvastatin—coronary artery disease	0.00641	0.0201	CbGbCtD
Ergotamine—ABCB1—Pravastatin—coronary artery disease	0.00628	0.0197	CbGbCtD
Ergotamine—ABCB1—Lovastatin—coronary artery disease	0.00628	0.0197	CbGbCtD
Ergotamine—CYP1A2—Losartan—coronary artery disease	0.00598	0.0188	CbGbCtD
Ergotamine—CYP3A4—Eplerenone—coronary artery disease	0.00596	0.0187	CbGbCtD
Ergotamine—ABCB1—Atorvastatin—coronary artery disease	0.00572	0.0179	CbGbCtD
Ergotamine—CYP3A4—Enalapril—coronary artery disease	0.00532	0.0167	CbGbCtD
Ergotamine—ABCB1—Losartan—coronary artery disease	0.00523	0.0164	CbGbCtD
Ergotamine—CYP3A4—Rosuvastatin—coronary artery disease	0.00413	0.013	CbGbCtD
Ergotamine—CYP3A4—Ezetimibe—coronary artery disease	0.00413	0.013	CbGbCtD
Ergotamine—CYP3A4—Simvastatin—coronary artery disease	0.00384	0.0121	CbGbCtD
Ergotamine—CYP3A4—Lovastatin—coronary artery disease	0.00376	0.0118	CbGbCtD
Ergotamine—CYP3A4—Pravastatin—coronary artery disease	0.00376	0.0118	CbGbCtD
Ergotamine—CYP3A4—Atorvastatin—coronary artery disease	0.00343	0.0108	CbGbCtD
Ergotamine—CYP3A4—Losartan—coronary artery disease	0.00313	0.00983	CbGbCtD
Ergotamine—SLC6A2—sympathetic nervous system—coronary artery disease	0.00229	0.0861	CbGeAlD
Ergotamine—HTR2A—arteriole—coronary artery disease	0.00216	0.0812	CbGeAlD
Ergotamine—SLC6A2—autonomic nervous system—coronary artery disease	0.00154	0.0579	CbGeAlD
Ergotamine—HTR2A—pulmonary artery—coronary artery disease	0.00142	0.0532	CbGeAlD
Ergotamine—HTR2A—sympathetic nervous system—coronary artery disease	0.00138	0.0518	CbGeAlD
Ergotamine—HTR2A—vagus nerve—coronary artery disease	0.00134	0.0501	CbGeAlD
Ergotamine—HTR2A—vein—coronary artery disease	0.00129	0.0484	CbGeAlD
Ergotamine—Peripheral coldness—Perindopril—coronary artery disease	0.00129	0.0209	CcSEcCtD
Ergotamine—HTR1B—artery—coronary artery disease	0.00109	0.041	CbGeAlD
Ergotamine—HTR1D—artery—coronary artery disease	0.00106	0.0397	CbGeAlD
Ergotamine—Peripheral coldness—Timolol—coronary artery disease	0.00101	0.0164	CcSEcCtD
Ergotamine—HTR2A—autonomic nervous system—coronary artery disease	0.000927	0.0348	CbGeAlD
Ergotamine—Bradycardia—Tirofiban—coronary artery disease	0.000915	0.0148	CcSEcCtD
Ergotamine—Numbness—Pravastatin—coronary artery disease	0.000823	0.0133	CcSEcCtD
Ergotamine—Sensory loss—Pravastatin—coronary artery disease	0.000787	0.0127	CcSEcCtD
Ergotamine—Hypoaesthesia—Pitavastatin—coronary artery disease	0.000763	0.0124	CcSEcCtD
Ergotamine—Hypertension—Tirofiban—coronary artery disease	0.000675	0.0109	CcSEcCtD
Ergotamine—Bradycardia—Penbutolol—coronary artery disease	0.000649	0.0105	CcSEcCtD
Ergotamine—Myalgia—Pitavastatin—coronary artery disease	0.000569	0.00921	CcSEcCtD
Ergotamine—Pain—Tirofiban—coronary artery disease	0.000546	0.00884	CcSEcCtD
Ergotamine—Hypoaesthesia—Gemfibrozil—coronary artery disease	0.000541	0.00876	CcSEcCtD
Ergotamine—Bradycardia—Ticagrelor—coronary artery disease	0.00054	0.00875	CcSEcCtD
Ergotamine—HTR2A—artery—coronary artery disease	0.000526	0.0197	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Pitavastatin—coronary artery disease	0.000497	0.00804	CcSEcCtD
Ergotamine—HTR2A—endothelium—coronary artery disease	0.000444	0.0167	CbGeAlD
Ergotamine—Vertigo—Gemfibrozil—coronary artery disease	0.000425	0.00688	CcSEcCtD
Ergotamine—Vertigo—Ticagrelor—coronary artery disease	0.000415	0.00672	CcSEcCtD
Ergotamine—Hypoaesthesia—Clopidogrel—coronary artery disease	0.000406	0.00657	CcSEcCtD
Ergotamine—Myalgia—Gemfibrozil—coronary artery disease	0.000403	0.00652	CcSEcCtD
Ergotamine—Hypertension—Ticagrelor—coronary artery disease	0.000399	0.00646	CcSEcCtD
Ergotamine—Asthenia—Pitavastatin—coronary artery disease	0.000391	0.00633	CcSEcCtD
Ergotamine—Pain—Penbutolol—coronary artery disease	0.000387	0.00627	CcSEcCtD
Ergotamine—Hypoaesthesia—Eplerenone—coronary artery disease	0.000387	0.00626	CcSEcCtD
Ergotamine—Pruritus—Pitavastatin—coronary artery disease	0.000386	0.00624	CcSEcCtD
Ergotamine—HTR1B—cardiovascular system—coronary artery disease	0.00038	0.0143	CbGeAlD
Ergotamine—Nausea—Tirofiban—coronary artery disease	0.000379	0.00614	CcSEcCtD
Ergotamine—Methysergide—HTR7—coronary artery disease	0.000373	0.202	CrCbGaD
Ergotamine—HTR1D—cardiovascular system—coronary artery disease	0.000368	0.0138	CbGeAlD
Ergotamine—Vertigo—Acetylsalicylic acid—coronary artery disease	0.000363	0.00588	CcSEcCtD
Ergotamine—HTR2B—heart—coronary artery disease	0.000363	0.0136	CbGeAlD
Ergotamine—Myalgia—Rosuvastatin—coronary artery disease	0.000354	0.00573	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Gemfibrozil—coronary artery disease	0.000352	0.0057	CcSEcCtD
Ergotamine—Hypertension—Acetylsalicylic acid—coronary artery disease	0.000349	0.00565	CcSEcCtD
Ergotamine—Paraesthesia—Gemfibrozil—coronary artery disease	0.000347	0.00561	CcSEcCtD
Ergotamine—Hypoaesthesia—Niacin—coronary artery disease	0.000346	0.0056	CcSEcCtD
Ergotamine—HTR2B—cardiovascular system—coronary artery disease	0.000342	0.0128	CbGeAlD
Ergotamine—Hypoaesthesia—Pravastatin—coronary artery disease	0.000341	0.00552	CcSEcCtD
Ergotamine—Paraesthesia—Ticagrelor—coronary artery disease	0.000339	0.00548	CcSEcCtD
Ergotamine—Bradycardia—Trandolapril—coronary artery disease	0.000339	0.00548	CcSEcCtD
Ergotamine—Bradycardia—Enalapril—coronary artery disease	0.000337	0.00546	CcSEcCtD
Ergotamine—Bradycardia—Telmisartan—coronary artery disease	0.000333	0.00539	CcSEcCtD
Ergotamine—Pain—Gemfibrozil—coronary artery disease	0.00033	0.00535	CcSEcCtD
Ergotamine—Hypoaesthesia—Telmisartan—coronary artery disease	0.000325	0.00526	CcSEcCtD
Ergotamine—Asthenia—Penbutolol—coronary artery disease	0.000325	0.00526	CcSEcCtD
Ergotamine—Vertigo—Fenofibrate—coronary artery disease	0.000324	0.00525	CcSEcCtD
Ergotamine—Nausea—Pitavastatin—coronary artery disease	0.000324	0.00524	CcSEcCtD
Ergotamine—Tachycardia—Acetylsalicylic acid—coronary artery disease	0.000322	0.00521	CcSEcCtD
Ergotamine—Vertigo—Clopidogrel—coronary artery disease	0.000319	0.00516	CcSEcCtD
Ergotamine—Vertigo—Lovastatin—coronary artery disease	0.000317	0.00513	CcSEcCtD
Ergotamine—Bradycardia—Perindopril—coronary artery disease	0.000314	0.00508	CcSEcCtD
Ergotamine—Hypertension—Fenofibrate—coronary artery disease	0.000312	0.00505	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Rosuvastatin—coronary artery disease	0.000309	0.00501	CcSEcCtD
Ergotamine—Myalgia—Fenofibrate—coronary artery disease	0.000307	0.00498	CcSEcCtD
Ergotamine—HTR1A—cardiovascular system—coronary artery disease	0.000307	0.0115	CbGeAlD
Ergotamine—Hypertension—Clopidogrel—coronary artery disease	0.000306	0.00496	CcSEcCtD
Ergotamine—Paraesthesia—Rosuvastatin—coronary artery disease	0.000305	0.00494	CcSEcCtD
Ergotamine—Myalgia—Clopidogrel—coronary artery disease	0.000302	0.00489	CcSEcCtD
Ergotamine—Myalgia—Lovastatin—coronary artery disease	0.0003	0.00486	CcSEcCtD
Ergotamine—ADRA1A—heart—coronary artery disease	0.000299	0.0112	CbGeAlD
Ergotamine—Hypertension—Ezetimibe—coronary artery disease	0.000299	0.00483	CcSEcCtD
Ergotamine—Vertigo—Simvastatin—coronary artery disease	0.000296	0.0048	CcSEcCtD
Ergotamine—Myalgia—Ezetimibe—coronary artery disease	0.000294	0.00477	CcSEcCtD
Ergotamine—Pain—Rosuvastatin—coronary artery disease	0.00029	0.0047	CcSEcCtD
Ergotamine—Myalgia—Eplerenone—coronary artery disease	0.000288	0.00467	CcSEcCtD
Ergotamine—Hypoaesthesia—Losartan—coronary artery disease	0.000288	0.00466	CcSEcCtD
Ergotamine—Tachycardia—Fenofibrate—coronary artery disease	0.000288	0.00466	CcSEcCtD
Ergotamine—ADRA1A—cardiovascular system—coronary artery disease	0.000283	0.0106	CbGeAlD
Ergotamine—Myalgia—Simvastatin—coronary artery disease	0.000281	0.00455	CcSEcCtD
Ergotamine—Vertigo—Valsartan—coronary artery disease	0.00028	0.00453	CcSEcCtD
Ergotamine—Vertigo—Olmesartan—coronary artery disease	0.000278	0.00451	CcSEcCtD
Ergotamine—Bromocriptine—HTR7—coronary artery disease	0.000278	0.15	CrCbGaD
Ergotamine—Asthenia—Gemfibrozil—coronary artery disease	0.000277	0.00449	CcSEcCtD
Ergotamine—Pruritus—Gemfibrozil—coronary artery disease	0.000273	0.00442	CcSEcCtD
Ergotamine—Vertigo—Niacin—coronary artery disease	0.000272	0.0044	CcSEcCtD
Ergotamine—Asthenia—Ticagrelor—coronary artery disease	0.000271	0.00438	CcSEcCtD
Ergotamine—HTR2B—blood—coronary artery disease	0.000271	0.0102	CbGeAlD
Ergotamine—Nausea—Penbutolol—coronary artery disease	0.000269	0.00435	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Fenofibrate—coronary artery disease	0.000268	0.00435	CcSEcCtD
Ergotamine—Vertigo—Pravastatin—coronary artery disease	0.000268	0.00434	CcSEcCtD
Ergotamine—Pruritus—Ticagrelor—coronary artery disease	0.000267	0.00432	CcSEcCtD
Ergotamine—Myalgia—Valsartan—coronary artery disease	0.000265	0.00429	CcSEcCtD
Ergotamine—Paraesthesia—Fenofibrate—coronary artery disease	0.000265	0.00428	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Clopidogrel—coronary artery disease	0.000264	0.00427	CcSEcCtD
Ergotamine—Myalgia—Olmesartan—coronary artery disease	0.000264	0.00427	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Lovastatin—coronary artery disease	0.000262	0.00424	CcSEcCtD
Ergotamine—Vertigo—Trandolapril—coronary artery disease	0.00026	0.00421	CcSEcCtD
Ergotamine—Paraesthesia—Clopidogrel—coronary artery disease	0.00026	0.00421	CcSEcCtD
Ergotamine—Vertigo—Enalapril—coronary artery disease	0.000259	0.00419	CcSEcCtD
Ergotamine—Paraesthesia—Lovastatin—coronary artery disease	0.000258	0.00418	CcSEcCtD
Ergotamine—Myalgia—Niacin—coronary artery disease	0.000258	0.00417	CcSEcCtD
Ergotamine—Hypertension—Pravastatin—coronary artery disease	0.000257	0.00417	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Ezetimibe—coronary artery disease	0.000257	0.00416	CcSEcCtD
Ergotamine—Lisuride—ADRB1—coronary artery disease	0.000257	0.139	CrCbGaD
Ergotamine—Vertigo—Telmisartan—coronary artery disease	0.000256	0.00414	CcSEcCtD
Ergotamine—Myalgia—Pravastatin—coronary artery disease	0.000254	0.00411	CcSEcCtD
Ergotamine—Paraesthesia—Ezetimibe—coronary artery disease	0.000253	0.0041	CcSEcCtD
Ergotamine—Pain—Fenofibrate—coronary artery disease	0.000252	0.00408	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Eplerenone—coronary artery disease	0.000252	0.00407	CcSEcCtD
Ergotamine—Pain—Clopidogrel—coronary artery disease	0.000248	0.00401	CcSEcCtD
Ergotamine—Bradycardia—Timolol—coronary artery disease	0.000247	0.004	CcSEcCtD
Ergotamine—Tachycardia—Olmesartan—coronary artery disease	0.000247	0.004	CcSEcCtD
Ergotamine—Myalgia—Trandolapril—coronary artery disease	0.000246	0.00399	CcSEcCtD
Ergotamine—Pain—Lovastatin—coronary artery disease	0.000246	0.00398	CcSEcCtD
Ergotamine—Hypertension—Telmisartan—coronary artery disease	0.000246	0.00398	CcSEcCtD
Ergotamine—Vomiting—Gemfibrozil—coronary artery disease	0.000246	0.00398	CcSEcCtD
Ergotamine—Myalgia—Enalapril—coronary artery disease	0.000246	0.00397	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Simvastatin—coronary artery disease	0.000245	0.00397	CcSEcCtD
Ergotamine—Asthenia—Rosuvastatin—coronary artery disease	0.000244	0.00394	CcSEcCtD
Ergotamine—Myalgia—Telmisartan—coronary artery disease	0.000242	0.00392	CcSEcCtD
Ergotamine—Paraesthesia—Simvastatin—coronary artery disease	0.000242	0.00391	CcSEcCtD
Ergotamine—Pain—Ezetimibe—coronary artery disease	0.000241	0.00391	CcSEcCtD
Ergotamine—Vertigo—Perindopril—coronary artery disease	0.000241	0.00391	CcSEcCtD
Ergotamine—Tachycardia—Niacin—coronary artery disease	0.000241	0.00391	CcSEcCtD
Ergotamine—Pruritus—Rosuvastatin—coronary artery disease	0.00024	0.00389	CcSEcCtD
Ergotamine—Vomiting—Ticagrelor—coronary artery disease	0.00024	0.00388	CcSEcCtD
Ergotamine—Bromocriptine—ADRB1—coronary artery disease	0.000238	0.129	CrCbGaD
Ergotamine—Pain—Eplerenone—coronary artery disease	0.000236	0.00382	CcSEcCtD
Ergotamine—Myalgia—Captopril—coronary artery disease	0.000235	0.00381	CcSEcCtD
Ergotamine—Vertigo—Furosemide—coronary artery disease	0.000235	0.0038	CcSEcCtD
Ergotamine—Pruritus—Acetylsalicylic acid—coronary artery disease	0.000233	0.00378	CcSEcCtD
Ergotamine—Hypertension—Perindopril—coronary artery disease	0.000232	0.00375	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Valsartan—coronary artery disease	0.000232	0.00375	CcSEcCtD
Ergotamine—Tachycardia—Trandolapril—coronary artery disease	0.000231	0.00373	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Olmesartan—coronary artery disease	0.00023	0.00373	CcSEcCtD
Ergotamine—Pain—Simvastatin—coronary artery disease	0.00023	0.00373	CcSEcCtD
Ergotamine—Tachycardia—Enalapril—coronary artery disease	0.00023	0.00372	CcSEcCtD
Ergotamine—Nausea—Gemfibrozil—coronary artery disease	0.000229	0.00371	CcSEcCtD
Ergotamine—Bradycardia—Lisinopril—coronary artery disease	0.000229	0.00371	CcSEcCtD
Ergotamine—Myalgia—Perindopril—coronary artery disease	0.000229	0.0037	CcSEcCtD
Ergotamine—Paraesthesia—Valsartan—coronary artery disease	0.000228	0.0037	CcSEcCtD
Ergotamine—ADRA2A—heart—coronary artery disease	0.000228	0.00855	CbGeAlD
Ergotamine—Tachycardia—Telmisartan—coronary artery disease	0.000227	0.00367	CcSEcCtD
Ergotamine—Vertigo—Losartan—coronary artery disease	0.000226	0.00366	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Niacin—coronary artery disease	0.000225	0.00365	CcSEcCtD
Ergotamine—Methylergometrine—HTR2A—coronary artery disease	0.000225	0.122	CrCbGaD
Ergotamine—Nausea—Ticagrelor—coronary artery disease	0.000224	0.00363	CcSEcCtD
Ergotamine—ADRA1A—blood—coronary artery disease	0.000223	0.00839	CbGeAlD
Ergotamine—Paraesthesia—Niacin—coronary artery disease	0.000222	0.00359	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Pravastatin—coronary artery disease	0.000222	0.00359	CcSEcCtD
Ergotamine—Tachycardia—Captopril—coronary artery disease	0.00022	0.00357	CcSEcCtD
Ergotamine—Paraesthesia—Pravastatin—coronary artery disease	0.000218	0.00354	CcSEcCtD
Ergotamine—Pain—Olmesartan—coronary artery disease	0.000216	0.0035	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Trandolapril—coronary artery disease	0.000215	0.00349	CcSEcCtD
Ergotamine—Myalgia—Losartan—coronary artery disease	0.000214	0.00347	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Enalapril—coronary artery disease	0.000214	0.00347	CcSEcCtD
Ergotamine—Tachycardia—Perindopril—coronary artery disease	0.000214	0.00346	CcSEcCtD
Ergotamine—Paraesthesia—Trandolapril—coronary artery disease	0.000212	0.00344	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Telmisartan—coronary artery disease	0.000211	0.00342	CcSEcCtD
Ergotamine—Asthenia—Fenofibrate—coronary artery disease	0.000211	0.00342	CcSEcCtD
Ergotamine—Pain—Niacin—coronary artery disease	0.000211	0.00342	CcSEcCtD
Ergotamine—Paraesthesia—Enalapril—coronary artery disease	0.000211	0.00342	CcSEcCtD
Ergotamine—Vomiting—Acetylsalicylic acid—coronary artery disease	0.00021	0.0034	CcSEcCtD
Ergotamine—Pruritus—Fenofibrate—coronary artery disease	0.000208	0.00338	CcSEcCtD
Ergotamine—Paraesthesia—Telmisartan—coronary artery disease	0.000208	0.00337	CcSEcCtD
Ergotamine—Pain—Pravastatin—coronary artery disease	0.000208	0.00337	CcSEcCtD
Ergotamine—Asthenia—Clopidogrel—coronary artery disease	0.000208	0.00336	CcSEcCtD
Ergotamine—Asthenia—Lovastatin—coronary artery disease	0.000206	0.00334	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Captopril—coronary artery disease	0.000206	0.00333	CcSEcCtD
Ergotamine—Pruritus—Clopidogrel—coronary artery disease	0.000205	0.00332	CcSEcCtD
Ergotamine—Pruritus—Lovastatin—coronary artery disease	0.000204	0.0033	CcSEcCtD
Ergotamine—Paraesthesia—Captopril—coronary artery disease	0.000203	0.00328	CcSEcCtD
Ergotamine—Asthenia—Ezetimibe—coronary artery disease	0.000202	0.00328	CcSEcCtD
Ergotamine—Nausea—Rosuvastatin—coronary artery disease	0.000202	0.00327	CcSEcCtD
Ergotamine—Tachycardia—Losartan—coronary artery disease	0.000201	0.00325	CcSEcCtD
Ergotamine—Pruritus—Ezetimibe—coronary artery disease	0.0002	0.00323	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.0002	0.00323	CcSEcCtD
Ergotamine—Pain—Telmisartan—coronary artery disease	0.000199	0.00321	CcSEcCtD
Ergotamine—Asthenia—Eplerenone—coronary artery disease	0.000198	0.00321	CcSEcCtD
Ergotamine—Paraesthesia—Perindopril—coronary artery disease	0.000197	0.00319	CcSEcCtD
Ergotamine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000196	0.00317	CcSEcCtD
Ergotamine—Pruritus—Eplerenone—coronary artery disease	0.000195	0.00316	CcSEcCtD
Ergotamine—ADRA2A—cardiac atrium—coronary artery disease	0.000195	0.00731	CbGeAlD
Ergotamine—Vertigo—Ramipril—coronary artery disease	0.000194	0.00314	CcSEcCtD
Ergotamine—HTR2A—heart—coronary artery disease	0.000194	0.00727	CbGeAlD
Ergotamine—Asthenia—Simvastatin—coronary artery disease	0.000193	0.00313	CcSEcCtD
Ergotamine—Paraesthesia—Furosemide—coronary artery disease	0.000191	0.0031	CcSEcCtD
Ergotamine—Pruritus—Simvastatin—coronary artery disease	0.00019	0.00308	CcSEcCtD
Ergotamine—Vertigo—Timolol—coronary artery disease	0.00019	0.00307	CcSEcCtD
Ergotamine—Methysergide—HTR2A—coronary artery disease	0.000187	0.101	CrCbGaD
Ergotamine—Pain—Perindopril—coronary artery disease	0.000187	0.00303	CcSEcCtD
Ergotamine—Vomiting—Fenofibrate—coronary artery disease	0.000187	0.00303	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000187	0.00303	CcSEcCtD
Ergotamine—CYP1A2—blood—coronary artery disease	0.000185	0.00694	CbGeAlD
Ergotamine—Paraesthesia—Losartan—coronary artery disease	0.000185	0.00299	CcSEcCtD
Ergotamine—Vomiting—Clopidogrel—coronary artery disease	0.000184	0.00298	CcSEcCtD
Ergotamine—Myalgia—Ramipril—coronary artery disease	0.000184	0.00298	CcSEcCtD
Ergotamine—Vomiting—Lovastatin—coronary artery disease	0.000183	0.00296	CcSEcCtD
Ergotamine—HTR2A—cardiovascular system—coronary artery disease	0.000183	0.00686	CbGeAlD
Ergotamine—Asthenia—Valsartan—coronary artery disease	0.000182	0.00295	CcSEcCtD
Ergotamine—Hypertension—Timolol—coronary artery disease	0.000182	0.00295	CcSEcCtD
Ergotamine—Pain—Furosemide—coronary artery disease	0.000182	0.00295	CcSEcCtD
Ergotamine—Asthenia—Olmesartan—coronary artery disease	0.000181	0.00294	CcSEcCtD
Ergotamine—Pruritus—Valsartan—coronary artery disease	0.00018	0.00291	CcSEcCtD
Ergotamine—Myalgia—Timolol—coronary artery disease	0.00018	0.00291	CcSEcCtD
Ergotamine—Vomiting—Ezetimibe—coronary artery disease	0.000179	0.00291	CcSEcCtD
Ergotamine—Pruritus—Olmesartan—coronary artery disease	0.000179	0.0029	CcSEcCtD
Ergotamine—Asthenia—Niacin—coronary artery disease	0.000177	0.00287	CcSEcCtD
Ergotamine—Vertigo—Lisinopril—coronary artery disease	0.000176	0.00285	CcSEcCtD
Ergotamine—Pain—Losartan—coronary artery disease	0.000176	0.00285	CcSEcCtD
Ergotamine—Vomiting—Eplerenone—coronary artery disease	0.000176	0.00284	CcSEcCtD
Ergotamine—Nausea—Fenofibrate—coronary artery disease	0.000175	0.00283	CcSEcCtD
Ergotamine—Pruritus—Niacin—coronary artery disease	0.000175	0.00283	CcSEcCtD
Ergotamine—Asthenia—Pravastatin—coronary artery disease	0.000175	0.00283	CcSEcCtD
Ergotamine—Pruritus—Pravastatin—coronary artery disease	0.000172	0.00279	CcSEcCtD
Ergotamine—Nausea—Clopidogrel—coronary artery disease	0.000172	0.00279	CcSEcCtD
Ergotamine—Tachycardia—Ramipril—coronary artery disease	0.000172	0.00279	CcSEcCtD
Ergotamine—Vomiting—Simvastatin—coronary artery disease	0.000171	0.00277	CcSEcCtD
Ergotamine—Nausea—Lovastatin—coronary artery disease	0.000171	0.00277	CcSEcCtD
Ergotamine—ADRA2A—blood—coronary artery disease	0.00017	0.00638	CbGeAlD
Ergotamine—Asthenia—Trandolapril—coronary artery disease	0.00017	0.00274	CcSEcCtD
Ergotamine—Asthenia—Enalapril—coronary artery disease	0.000169	0.00273	CcSEcCtD
Ergotamine—Nausea—Ezetimibe—coronary artery disease	0.000168	0.00271	CcSEcCtD
Ergotamine—Pruritus—Trandolapril—coronary artery disease	0.000167	0.00271	CcSEcCtD
Ergotamine—Myalgia—Lisinopril—coronary artery disease	0.000167	0.0027	CcSEcCtD
Ergotamine—Asthenia—Telmisartan—coronary artery disease	0.000167	0.0027	CcSEcCtD
Ergotamine—Pruritus—Enalapril—coronary artery disease	0.000167	0.0027	CcSEcCtD
Ergotamine—Pruritus—Telmisartan—coronary artery disease	0.000164	0.00266	CcSEcCtD
Ergotamine—Nausea—Eplerenone—coronary artery disease	0.000164	0.00266	CcSEcCtD
Ergotamine—Asthenia—Captopril—coronary artery disease	0.000162	0.00262	CcSEcCtD
Ergotamine—Vomiting—Valsartan—coronary artery disease	0.000162	0.00262	CcSEcCtD
Ergotamine—Vomiting—Olmesartan—coronary artery disease	0.000161	0.0026	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000161	0.0026	CcSEcCtD
Ergotamine—Nausea—Simvastatin—coronary artery disease	0.00016	0.00259	CcSEcCtD
Ergotamine—Pruritus—Captopril—coronary artery disease	0.00016	0.00259	CcSEcCtD
Ergotamine—Paraesthesia—Ramipril—coronary artery disease	0.000158	0.00256	CcSEcCtD
Ergotamine—Asthenia—Perindopril—coronary artery disease	0.000157	0.00255	CcSEcCtD
Ergotamine—Vomiting—Niacin—coronary artery disease	0.000157	0.00254	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000157	0.00254	CcSEcCtD
Ergotamine—Tachycardia—Lisinopril—coronary artery disease	0.000156	0.00253	CcSEcCtD
Ergotamine—Pruritus—Perindopril—coronary artery disease	0.000155	0.00251	CcSEcCtD
Ergotamine—Paraesthesia—Timolol—coronary artery disease	0.000155	0.00251	CcSEcCtD
Ergotamine—Vomiting—Pravastatin—coronary artery disease	0.000155	0.0025	CcSEcCtD
Ergotamine—Asthenia—Furosemide—coronary artery disease	0.000153	0.00247	CcSEcCtD
Ergotamine—Nausea—Valsartan—coronary artery disease	0.000151	0.00244	CcSEcCtD
Ergotamine—Pruritus—Furosemide—coronary artery disease	0.000151	0.00244	CcSEcCtD
Ergotamine—Lisuride—HTR2A—coronary artery disease	0.000151	0.0815	CrCbGaD
Ergotamine—Nausea—Olmesartan—coronary artery disease	0.00015	0.00243	CcSEcCtD
Ergotamine—Vomiting—Trandolapril—coronary artery disease	0.00015	0.00243	CcSEcCtD
Ergotamine—Vomiting—Enalapril—coronary artery disease	0.00015	0.00242	CcSEcCtD
Ergotamine—Vomiting—Telmisartan—coronary artery disease	0.000148	0.00239	CcSEcCtD
Ergotamine—Asthenia—Losartan—coronary artery disease	0.000147	0.00239	CcSEcCtD
Ergotamine—Pain—Timolol—coronary artery disease	0.000147	0.00239	CcSEcCtD
Ergotamine—Nausea—Niacin—coronary artery disease	0.000147	0.00238	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000146	0.00236	CcSEcCtD
Ergotamine—Pruritus—Losartan—coronary artery disease	0.000145	0.00235	CcSEcCtD
Ergotamine—Nausea—Pravastatin—coronary artery disease	0.000145	0.00234	CcSEcCtD
Ergotamine—HTR2A—blood—coronary artery disease	0.000144	0.00542	CbGeAlD
Ergotamine—Paraesthesia—Lisinopril—coronary artery disease	0.000144	0.00232	CcSEcCtD
Ergotamine—Vomiting—Captopril—coronary artery disease	0.000144	0.00232	CcSEcCtD
Ergotamine—Nausea—Trandolapril—coronary artery disease	0.00014	0.00227	CcSEcCtD
Ergotamine—Nausea—Enalapril—coronary artery disease	0.00014	0.00226	CcSEcCtD
Ergotamine—Bromocriptine—HTR2A—coronary artery disease	0.00014	0.0755	CrCbGaD
Ergotamine—Vomiting—Perindopril—coronary artery disease	0.000139	0.00226	CcSEcCtD
Ergotamine—Nausea—Telmisartan—coronary artery disease	0.000138	0.00223	CcSEcCtD
Ergotamine—Pain—Lisinopril—coronary artery disease	0.000137	0.00221	CcSEcCtD
Ergotamine—Vomiting—Furosemide—coronary artery disease	0.000135	0.00219	CcSEcCtD
Ergotamine—Nausea—Captopril—coronary artery disease	0.000134	0.00217	CcSEcCtD
Ergotamine—CYP3A4—blood—coronary artery disease	0.000134	0.00502	CbGeAlD
Ergotamine—Vomiting—Losartan—coronary artery disease	0.000131	0.00212	CcSEcCtD
Ergotamine—Nausea—Perindopril—coronary artery disease	0.00013	0.00211	CcSEcCtD
Ergotamine—ABCB1—heart—coronary artery disease	0.000127	0.00476	CbGeAlD
Ergotamine—Nausea—Furosemide—coronary artery disease	0.000127	0.00205	CcSEcCtD
Ergotamine—Asthenia—Ramipril—coronary artery disease	0.000126	0.00205	CcSEcCtD
Ergotamine—Pruritus—Ramipril—coronary artery disease	0.000125	0.00202	CcSEcCtD
Ergotamine—Asthenia—Timolol—coronary artery disease	0.000124	0.002	CcSEcCtD
Ergotamine—Nausea—Losartan—coronary artery disease	0.000122	0.00198	CcSEcCtD
Ergotamine—Pruritus—Timolol—coronary artery disease	0.000122	0.00197	CcSEcCtD
Ergotamine—ABCB1—cardiovascular system—coronary artery disease	0.00012	0.00449	CbGeAlD
Ergotamine—Asthenia—Lisinopril—coronary artery disease	0.000115	0.00186	CcSEcCtD
Ergotamine—Pruritus—Lisinopril—coronary artery disease	0.000113	0.00183	CcSEcCtD
Ergotamine—Vomiting—Ramipril—coronary artery disease	0.000112	0.00181	CcSEcCtD
Ergotamine—Vomiting—Timolol—coronary artery disease	0.00011	0.00177	CcSEcCtD
Ergotamine—Nausea—Ramipril—coronary artery disease	0.000105	0.0017	CcSEcCtD
Ergotamine—Nausea—Timolol—coronary artery disease	0.000102	0.00166	CcSEcCtD
Ergotamine—Vomiting—Lisinopril—coronary artery disease	0.000102	0.00165	CcSEcCtD
Ergotamine—Nausea—Lisinopril—coronary artery disease	9.5e-05	0.00154	CcSEcCtD
Ergotamine—ABCB1—blood—coronary artery disease	9.47e-05	0.00355	CbGeAlD
Ergotamine—DRD2—Signaling Pathways—IGF1—coronary artery disease	1.34e-06	1.29e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—IL6—coronary artery disease	1.34e-06	1.29e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—JAK2—coronary artery disease	1.34e-06	1.29e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6R—coronary artery disease	1.34e-06	1.29e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—VEGFA—coronary artery disease	1.34e-06	1.29e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	1.34e-06	1.29e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	1.33e-06	1.28e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—AKT1—coronary artery disease	1.33e-06	1.28e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—AKT1—coronary artery disease	1.33e-06	1.28e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IGF1—coronary artery disease	1.32e-06	1.27e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	1.32e-06	1.27e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	1.32e-06	1.27e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	1.31e-06	1.26e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	1.31e-06	1.26e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CCND1—coronary artery disease	1.31e-06	1.26e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—PIK3CA—coronary artery disease	1.31e-06	1.26e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—KIT—coronary artery disease	1.31e-06	1.26e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	1.31e-06	1.26e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—VEGFA—coronary artery disease	1.31e-06	1.26e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.3e-06	1.25e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.3e-06	1.25e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—NOS3—coronary artery disease	1.3e-06	1.25e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	1.29e-06	1.24e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—MTHFR—coronary artery disease	1.29e-06	1.24e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	1.29e-06	1.24e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	1.28e-06	1.23e-05	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.28e-06	1.23e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MMP9—coronary artery disease	1.28e-06	1.23e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CTGF—coronary artery disease	1.27e-06	1.22e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	1.27e-06	1.22e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CXCL8—coronary artery disease	1.27e-06	1.22e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.27e-06	1.22e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GOT2—coronary artery disease	1.26e-06	1.21e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.26e-06	1.21e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—AKT1—coronary artery disease	1.26e-06	1.21e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	1.26e-06	1.21e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.26e-06	1.21e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	1.26e-06	1.21e-05	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.26e-06	1.21e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	1.25e-06	1.2e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.25e-06	1.2e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	1.25e-06	1.2e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—POMC—coronary artery disease	1.25e-06	1.2e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	1.24e-06	1.19e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CAT—coronary artery disease	1.23e-06	1.19e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—FGF2—coronary artery disease	1.23e-06	1.18e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—VEGFA—coronary artery disease	1.23e-06	1.18e-05	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	1.23e-06	1.18e-05	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.23e-06	1.18e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	1.23e-06	1.18e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TGFB1—coronary artery disease	1.23e-06	1.18e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	1.23e-06	1.18e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—AGT—coronary artery disease	1.23e-06	1.18e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	1.22e-06	1.17e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	1.22e-06	1.17e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	1.22e-06	1.17e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	1.22e-06	1.17e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NOS3—coronary artery disease	1.22e-06	1.17e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—FGF2—coronary artery disease	1.21e-06	1.17e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	1.21e-06	1.16e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MAPK1—coronary artery disease	1.2e-06	1.16e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	1.2e-06	1.16e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—APOE—coronary artery disease	1.2e-06	1.15e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	1.2e-06	1.15e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—APOB—coronary artery disease	1.2e-06	1.15e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NOS3—coronary artery disease	1.2e-06	1.15e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	1.19e-06	1.15e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PTGS2—coronary artery disease	1.19e-06	1.14e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	1.19e-06	1.14e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—APOA1—coronary artery disease	1.19e-06	1.14e-05	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	1.19e-06	1.14e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	1.19e-06	1.14e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—JAK2—coronary artery disease	1.18e-06	1.14e-05	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	1.18e-06	1.13e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	1.18e-06	1.13e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CASP3—coronary artery disease	1.18e-06	1.13e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	1.17e-06	1.13e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	1.17e-06	1.12e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	1.17e-06	1.12e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL6—coronary artery disease	1.17e-06	1.12e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.17e-06	1.12e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	1.16e-06	1.12e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	1.16e-06	1.12e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.16e-06	1.12e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	1.16e-06	1.11e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	1.15e-06	1.11e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	1.14e-06	1.1e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CCND1—coronary artery disease	1.14e-06	1.1e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—LPL—coronary artery disease	1.14e-06	1.1e-05	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.14e-06	1.1e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	1.14e-06	1.1e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.14e-06	1.1e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	1.14e-06	1.09e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	1.14e-06	1.09e-05	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	1.13e-06	1.09e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	1.13e-06	1.09e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.13e-06	1.08e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	1.12e-06	1.08e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GPX1—coronary artery disease	1.12e-06	1.07e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	1.12e-06	1.07e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	1.12e-06	1.07e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	1.11e-06	1.07e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MMP9—coronary artery disease	1.11e-06	1.07e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	1.11e-06	1.06e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	1.11e-06	1.06e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	1.1e-06	1.06e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GOT1—coronary artery disease	1.09e-06	1.05e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GGT1—coronary artery disease	1.09e-06	1.05e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	1.09e-06	1.05e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	1.09e-06	1.05e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CD36—coronary artery disease	1.09e-06	1.04e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CXCL8—coronary artery disease	1.08e-06	1.04e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	1.08e-06	1.04e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.07e-06	1.03e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	1.07e-06	1.03e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	1.06e-06	1.02e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	1.06e-06	1.02e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	1.06e-06	1.02e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	1.05e-06	1.01e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PPARG—coronary artery disease	1.05e-06	1.01e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	1.04e-06	1e-05	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	1.04e-06	1e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	1.04e-06	9.99e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.04e-06	9.96e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	1.03e-06	9.93e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CASP3—coronary artery disease	1.03e-06	9.92e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—POMC—coronary artery disease	1.03e-06	9.92e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	1.03e-06	9.9e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.03e-06	9.9e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	1.03e-06	9.86e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL6—coronary artery disease	1.03e-06	9.86e-06	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	1.03e-06	9.85e-06	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	1.02e-06	9.83e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	1.02e-06	9.76e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	1.01e-06	9.7e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCND1—coronary artery disease	1e-06	9.66e-06	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	1e-06	9.65e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	9.98e-07	9.59e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	9.95e-07	9.56e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	9.93e-07	9.54e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	9.89e-07	9.5e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	9.88e-07	9.5e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GSTP1—coronary artery disease	9.79e-07	9.41e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—AGT—coronary artery disease	9.79e-07	9.41e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MMP9—coronary artery disease	9.76e-07	9.37e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	9.7e-07	9.32e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	9.68e-07	9.3e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—HMOX1—coronary artery disease	9.66e-07	9.28e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	9.66e-07	9.28e-06	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	9.61e-07	9.23e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	9.6e-07	9.22e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—APOE—coronary artery disease	9.59e-07	9.22e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CAT—coronary artery disease	9.53e-07	9.15e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	9.5e-07	9.13e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	9.49e-07	9.12e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—APOA1—coronary artery disease	9.48e-07	9.11e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—AKT1—coronary artery disease	9.46e-07	9.09e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ALB—coronary artery disease	9.41e-07	9.04e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	9.4e-07	9.03e-06	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	9.33e-07	8.96e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	9.31e-07	8.95e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	9.3e-07	8.94e-06	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL6—coronary artery disease	9.25e-07	8.89e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOB—coronary artery disease	9.25e-07	8.89e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	9.24e-07	8.88e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	9.18e-07	8.82e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	9.16e-07	8.8e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	9.12e-07	8.76e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	9.11e-07	8.75e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	9.08e-07	8.72e-06	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL6—coronary artery disease	9.06e-07	8.7e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—NOS3—coronary artery disease	9e-07	8.65e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GSTM1—coronary artery disease	9e-07	8.65e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	9e-07	8.64e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	8.98e-07	8.63e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	8.94e-07	8.59e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	8.94e-07	8.59e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—LPL—coronary artery disease	8.83e-07	8.49e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—VEGFA—coronary artery disease	8.76e-07	8.42e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	8.73e-07	8.39e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	8.72e-07	8.38e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	8.62e-07	8.28e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GPX1—coronary artery disease	8.62e-07	8.28e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	8.55e-07	8.22e-06	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AKT1—coronary artery disease	8.54e-07	8.2e-06	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL6—coronary artery disease	8.51e-07	8.18e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	8.47e-07	8.14e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	8.44e-07	8.11e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CD36—coronary artery disease	8.39e-07	8.06e-06	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AKT1—coronary artery disease	8.36e-07	8.03e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PPARG—coronary artery disease	8.36e-07	8.03e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	8.29e-07	7.96e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—POMC—coronary artery disease	8.24e-07	7.92e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PTGS2—coronary artery disease	8.23e-07	7.91e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	8.07e-07	7.76e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TGFB1—coronary artery disease	8.04e-07	7.73e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—MTHFR—coronary artery disease	7.95e-07	7.64e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL6—coronary artery disease	7.92e-07	7.61e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	7.91e-07	7.6e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MAPK1—coronary artery disease	7.89e-07	7.58e-06	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AKT1—coronary artery disease	7.85e-07	7.54e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	7.84e-07	7.54e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	7.79e-07	7.49e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	7.76e-07	7.46e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	7.75e-07	7.45e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	7.75e-07	7.44e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	7.6e-07	7.3e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—AGT—coronary artery disease	7.56e-07	7.26e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ALB—coronary artery disease	7.51e-07	7.22e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	7.42e-07	7.13e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOE—coronary artery disease	7.4e-07	7.11e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	7.33e-07	7.04e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOA1—coronary artery disease	7.32e-07	7.03e-06	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	7.31e-07	7.02e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	7.2e-07	6.92e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—NOS3—coronary artery disease	7.19e-07	6.91e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL6—coronary artery disease	7.15e-07	6.87e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	7.06e-07	6.78e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL6—coronary artery disease	6.9e-07	6.63e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL6—coronary artery disease	6.87e-07	6.6e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	6.84e-07	6.57e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	6.73e-07	6.47e-06	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	6.6e-07	6.34e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	6.59e-07	6.33e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PTGS2—coronary artery disease	6.57e-07	6.32e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL6—coronary artery disease	6.57e-07	6.31e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PPARG—coronary artery disease	6.45e-07	6.2e-06	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AKT1—coronary artery disease	6.37e-07	6.12e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—POMC—coronary artery disease	6.36e-07	6.11e-06	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	6.33e-07	6.09e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	6.13e-07	5.89e-06	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	6.06e-07	5.83e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL6—coronary artery disease	6.06e-07	5.82e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—AKT1—coronary artery disease	5.98e-07	5.75e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6—coronary artery disease	5.96e-07	5.73e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6—coronary artery disease	5.84e-07	5.61e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ALB—coronary artery disease	5.8e-07	5.57e-06	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AKT1—coronary artery disease	5.59e-07	5.37e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—NOS3—coronary artery disease	5.55e-07	5.33e-06	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	5.5e-07	5.28e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	5.42e-07	5.21e-06	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	5.39e-07	5.17e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PTGS2—coronary artery disease	5.07e-07	4.87e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PIK3CA—coronary artery disease	5.07e-07	4.87e-06	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	5e-07	4.81e-06	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—AKT1—coronary artery disease	4.14e-07	3.98e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	4.04e-07	3.89e-06	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—AKT1—coronary artery disease	3.3e-07	3.17e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.12e-07	3e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—AKT1—coronary artery disease	2.55e-07	2.45e-06	CbGpPWpGaD
